Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 National Biotechnology Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Poster Schedule
All Days
Mon, Apr 24
Tue, Apr 25
Poster Schedule
Type here to filter the list
Tuesday, April 25, 2023
10:30 AM – 11:30 AM
ET
(T1030-01-01) Selectivity of Human Cytokine Quantification in Human and Cyno Serum Using a Fully Automated Microfluidic Immunoassay System
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-02) Modification of Particle and Hardware Surfaces for Efficient Biotherapeutic Method Development
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-03) Tolerization with a Novel Tim Agonist Dual-Acting Liposomal Formulation Prepares the Immune System for the Success of Gene Therapy
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-04) Short-Term Tacrolimus/Sirolimus Combination Therapy Induces Long-Term Immune Tolerance to a Human Monoclonal Antibody in Rats
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-05) Assessing the Feasibility and Impact of Singlicate-Based Analysis for Clinical ADA Sample Analysis
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-06) Detection and Quantification of AAV Genome: Effects of Sample Pretreatment and Cross Platform Comparison of ddPCR and qPCR
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-07) Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-08) Conjugation Chemistry Used to Construct Protein-Coated Nanoparticles Determines Complement Activation and Associated Efficacy and Toxicity
Favorite
10:30 AM – 11:30 AM
ET
(T1030-01-09) Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-01) Strategies for Measuring Oligonucleotides Using a Fully Automated Microfluidic Immunoassay System
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-02) Evaluating a Merged Well Analysis Strategy for Validation of a Cellular Kinetics Assay to Quantify an Allogeneic Cell Product in Human Blood by ddPCR
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-04) Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-05) CARTs - A New Vehicle for Nucleic Acid Delivery with a Unique Controllable Release Mechanism
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-06) Development and Optimization of Next-Generation Lipid Nanoparticles for In Situ CAR-T Production
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-07) Current Strategies for Using Commercial Kit in Regulated Bioanalysis
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-08) Labelling AAV5 Capsid Reduced Its Binding Affinity to the Anti-AAV5 Antibody in Non-primate Human Serum Samples
Favorite
11:30 AM – 12:30 PM
ET
(T1130-01-09) Effect of Different Types of Dendrobium on the Gut Microbiota Alteration and Anti-diabetic Effect: In Vitro Screening and In Vivo Verification in db/db Mice
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-01) ST266 Amnion-Derived Mutipotent Cell Secretome for Prevention and Treatment of Necrotizing Enterocolitis
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-02) Screening and Epitope Binning of Anti-idiotypic Antibodies against Therapeutic Bispecific Antibodies Using the Gyros Immunoassay Platform
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-03) Harnessing Dendritic Cell Migration as a Predictor of Subcutaneous Immunogenicity Risk in a Mechanism-Based Screening Tool
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-04) Characterization and In Vivo Evaluation of Oil Based Anti-adhesion Agent with Xanthan Gum
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-06) Validation of PBPK-Based Translation to Predict Monoclonal Antibody Pharmacokinetics in Pediatric Populations
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-07) Preparation and Evaluation of Protein Encapsulated Liposome Using Surfactant for Dry Powder Inhalation
Favorite
1:30 PM – 2:30 PM
ET
(T1330-01-08) Multiplexed Quantification of CAR-T Subtypes by PCR
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-01) Alginate Hydrogels: A Tunable Tool for Biotech Applications
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-02) Preparation of PEG-b-PLA Nanoparticles via Inline Sonication for Controlled Release Applications
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-03) Bioanalytical Cross Validation: A More Statistically Based Approach to Establish Differences between Bioanalytical Methods and Laboratories
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-04) A Sensitive Electrochemiluminescence-Based Method for the Detection of Anti-drug Antibodies against Anti-PD-1 Antibody Drug Pembrolizumab in Human Serum
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-05) Mechanistic Investigation of Side-Effects of Lung Tropic Lipid Nanoparticles
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-06) Multiple Root Causes Impact Methionine Oxidation in a Coformulated Drug Product
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-07) Importance of Quality Control of In Vitro Transcribed RNA
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-08) Sensitization of Paclitaxel-Induced Apoptosis by Echinops giganteus Extract via Downregulation of PI3K/Akt/NF-κB Pathway and Enrichment of TIMP-3 in Cervical Cancer
Favorite
2:30 PM – 3:30 PM
ET
(T1430-01-09) An Orthogonal Bioanalytical Approach to Assess the Immunogenicity and Efficacy of Covid-19 Vaccines
Favorite
Back to Top
